UB Paderborn / Katalog / Suche / in CDI

Germline gene therapy: We're ready

Science (American Association for the Advancement of Science), 2015-06, Vol.348 (6241), p.1325-1325

Miller, Henry I.

2015

Link zum Volltext

Verfügbarkeit prüfen

Will the Biden administration 'follow the science' on regulatory reform?

Nature biotechnology, 2021-11, Vol.39 (11), p.1334-1335

2021

Link zum Volltext

Verfügbarkeit prüfen

Recasting Asilomar's lessons for human germline editing

Nature biotechnology, 2015-11, Vol.33 (11), p.1132-1134

Miller, Henry I

2015

Link zum Volltext

Verfügbarkeit prüfen

The Feds Act to Boost Competition in the Biosimilars Market

Missouri medicine, 2020-05, Vol.117 (3), p.196-198

Miller, Henry I

2020

Link zum Volltext

Verfügbarkeit prüfen

US Congress mandates silliness, USDA complies

Nature biotechnology, 2019-05, Vol.37 (5), p.497-498

2019

Link zum Volltext

Verfügbarkeit prüfen

We Can use Market Forces to Moderate Drug Prices

Missouri medicine, 2019-11, Vol.116 (6), p.451-453

Miller, Henry I

2019

Link zum Volltext

Verfügbarkeit prüfen

A Plea for the Renewal of the ISBR

Trends in biotechnology (Regular ed.), 2018-03, Vol.36 (3), p.229-231

2018

Link zum Volltext

Verfügbarkeit prüfen

FDA's 'Accelerated Approvals' Are Critical But Raise Thorny Issues

Missouri medicine, 2019-05, Vol.116 (3), p.168-169

Miller, Henry I

2019

Link zum Volltext

Verfügbarkeit prüfen

Basic research is often best appreciated in retrospect

Nature biotechnology, 2014-01, Vol.32 (1), p.24-25

Miller, Henry I

2014

Link zum Volltext

Verfügbarkeit prüfen

Buying 'Organic' to Get 'Authenticity'? Or Safer and More Nutritious Food? Think Again. And Again

Missouri medicine, 2019-01, Vol.116 (1), p.8-11

Miller, Henry I

2019

Link zum Volltext

Verfügbarkeit prüfen

What's behind a 'genetically engineered' label?

Nature biotechnology, 2015-05, Vol.33 (5), p.451-453

2015

Link zum Volltext

Verfügbarkeit prüfen

FDA is the wrong agency to regulate genetically engineered animals

Nature biotechnology, 2017-07, Vol.35 (7), p.620-622

2017

Link zum Volltext

Verfügbarkeit prüfen

Genetic engineering applied to agriculture has a long row to hoe

GM crops & food, 2018-01, Vol.9 (1), p.45-48

Miller, Henry I

2018

Link zum Volltext

Verfügbarkeit prüfen

Patients Suffer While the Science Establishment Resists Innovative Therapies

Journal of commercial biotechnology, 2018-04, Vol.24 (2), p.6

Miller, Henry I

2018

Link zum Volltext

Verfügbarkeit prüfen

USDA Reorganization Should Reduce Biotech Regulation and Feds’ Involvement in the Organic Industry

Journal of commercial biotechnology, 2020-01, Vol.25 (1), p.3

2020

Link zum Volltext

Verfügbarkeit prüfen

Personalized Medicine Needs Enlightened Regulation To Realize Its Potential

Journal of commercial biotechnology, 2017-10, Vol.23 (4), p.3

Miller, Henry I

2017

Link zum Volltext

Verfügbarkeit prüfen

Could COVID-19 Cause ‘Biopharming’ to Bloom?

Journal of commercial biotechnology, 2020-07, Vol.25 (3), p.34

2020

Link zum Volltext

Verfügbarkeit prüfen

The tarnished gold standard for GM risk assessment

GM crops & food, 2010-03, Vol.1 (2), p.59-61

Miller, Henry I.

2010

Link zum Volltext

Verfügbarkeit prüfen

Why an abbreviated FDA pathway for biosimilars is overhyped

Nature biotechnology, 2011-09, Vol.29 (9), p.794-795

Miller, Henry I

2011

Link zum Volltext

Verfügbarkeit prüfen

The regulation of agricultural biotechnology: science shows a better way

New biotechnology, 2010-11, Vol.27 (5), p.628-634

Miller, Henry I.

2010

Link zum Volltext

Verfügbarkeit prüfen

The UN's water torture

GM crops & food, 2010-01, Vol.1 (1), p.13-15

Miller, Henry I.

2010

Link zum Volltext

Verfügbarkeit prüfen

Flawed scientific studies block progress and sow confusion

GM crops & food, 2020-07, Vol.ahead-of-print (ahead-of-print), p.1-5

2020

Link zum Volltext

Verfügbarkeit prüfen

The U.N. celebrates a regulatory debacle

GM crops & food, 2018-10, Vol.9 (4), p.169-172

2018

Link zum Volltext

Verfügbarkeit prüfen

The flower industry gets the genetic engineering blues

GM crops & food, 2018-01, Vol.9 (2), p.49-52

2018

Link zum Volltext

Verfügbarkeit prüfen

Germline Gene Therapy: Don't Let Good Intentions Spawn Bad Policy

Issues in science and technology, 2016-04, Vol.32 (3), p.57-60

MILLER, HENRY I.

2016

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Germline gene therapy: We're ready

Will the Biden administration 'follow the science' on regulatory reform?

Recasting Asilomar's lessons for human germline editing

The Feds Act to Boost Competition in the Biosimilars Market

US Congress mandates silliness, USDA complies

We Can use Market Forces to Moderate Drug Prices

A Plea for the Renewal of the ISBR

FDA's 'Accelerated Approvals' Are Critical But Raise Thorny Issues

Basic research is often best appreciated in retrospect

Buying 'Organic' to Get 'Authenticity'? Or Safer and More Nutritious Food? Think Again. And Again

What's behind a 'genetically engineered' label?

FDA is the wrong agency to regulate genetically engineered animals

Genetic engineering applied to agriculture has a long row to hoe

Patients Suffer While the Science Establishment Resists Innovative Therapies

USDA Reorganization Should Reduce Biotech Regulation and Feds’ Involvement in the Organic Industry

Personalized Medicine Needs Enlightened Regulation To Realize Its Potential

Could COVID-19 Cause ‘Biopharming’ to Bloom?

The tarnished gold standard for GM risk assessment

Why an abbreviated FDA pathway for biosimilars is overhyped

The regulation of agricultural biotechnology: science shows a better way

The UN's water torture

Flawed scientific studies block progress and sow confusion

The U.N. celebrates a regulatory debacle

The flower industry gets the genetic engineering blues

Germline Gene Therapy: Don't Let Good Intentions Spawn Bad Policy

Suchergebnisse filtern